PolymarketKullanılabilirliği kontrol etKYC yok%2 ücretDoğrulanmış sonuçlanma verisiOrta düzey kalibreGüncel ima edilen olasılıkDecember 62%-0.5pt
Piyasa kalitesi
42 / 100
Düşük kalite24s Hacim
₺4,7 B
Likidite
₺37,3 B
Düşük likiditeAlis / Satis
21.0% / 25.0%
Spread
4.0 pt
Orta spread7g Değişim
-4.0 pts
Piyasa verileri
22 dakika önce guncellendi
23 Haz 26 2:1331 Ara 26 23:59
Trendler
Yalnızca sanal bakiye, gerçek para yokYatırım tavsiyesi değildir
Seçilen sonuç
December62%
Hacim trendi
$1003 Tem18g veri28 Tem
İlgili Piyasalar
When "Will Masking Return"? (widespread mask mandates in the USA)
₺53,7 BSeptember 2023: 1%MANIFOLD MARKETS
MANIFOLD MARKETSWill the NIH indirect cost cap stick?
₺47,4 BEvet: 11.4%MANIFOLD MARKETS
MANIFOLD MARKETSWill George W Bush outlive Obama?
₺24,4 BEvet: 12.3%MANIFOLD MARKETS
MANIFOLD MARKETS
California Clinic Funding Proposition
₺2,4 BEvet: 34%POLYMARKET
POLYMARKET
Who will Trump announce as next FDA commissioner?
₺2,1 BNo announcement by December 31: 41%POLYMARKET
POLYMARKET
What will the average number of measles cases be during Trump's term?
₺1,1 BAt least 4500: 43%
KALSHI
KALSHIBu konularda aktif
İlgili Haberler
Polymarket: Vance leads 2028 at 19.85% as pricing trend softensBlockchain.News
White House pushes Senate Democrats to take 'historic' crypto Clarity Act ethics dealCoindesk
Senate nears bipartisan CLARITY Act deal after ethics breakthroughCrypto News
White House agrees to ethics provisions in market structure billCointelegraph
Polymarket odds show Vance at 19.85% as Epstein files critique hits tapeBlockchain.News
Dick Durbin accuses Todd Blanche of shielding Trump’s crypto empireCrypto NewsKurallar
This market will resolve to “Yes” if the Food and Drug Administration (FDA) announces that it has reclassified or will reclassify BPC-157 to Category 1 of the Bulk Drug Substances List by the listed date, 11:59 PM ET.
- Otherwise, this market will resolve to “No”.
- A qualifying announcement must be official and public.
- Any rumored or private statements of intention will not qualify.
- Any announcement that the drug has been reclassified to Category 1 will qualify.
- Any announcement within this market’s timeframe of future intention to reclassify to Category 1 will qualify regardless of whether the reclassification has happened by the listed date.